What is the current size and annual growth rate of the robotic cardiology surgery market?
The robotic cardiology surgery market size has grown rapidly in recent years. It will grow from $0.72 billion in 2024 to $0.84 billion in 2025 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to rising adoption of robotic surgery in cardiology, growing preference for minimally invasive surgical procedures, rising incidence of cardiovascular diseases, growing healthcare expenditures, and growing aging population.
The robotic cardiology surgery market size is expected to see rapid growth in the next few years. It will grow to $1.54 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to increasing investment in advanced medical technologies, increasing telemedicine and remote surgery, rising number of surgical procedures, increasing prevalence of chronic diseases, and favorable regulatory environments, and the availability of reimbursement policies. Major trends in the forecast period include integration of artificial intelligence (AI) and machine learning algorithms, innovations in robotic technology, miniaturizing robotic components, product innovations, integrating 3D visualization, and incorporating features like motion scaling, and tremor filtering.
Get Your Free Sample of The Global Robotic Cardiology Surgery Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20615&type=smp
Which major factors have contributed to the expansion of the robotic cardiology surgery market?
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the robotic cardiology surgery market going forward. Cardiovascular disease (CVD) refers to a class of diseases that involve the heart or blood vessels. The increasing prevalence of cardiovascular diseases is due to a combination of lifestyle choices, medical conditions, genetic predisposition, and environmental factors. Robotic cardiology surgery plays a crucial role in advancing the treatment of cardiovascular diseases by providing safer, more precise, and less invasive surgical options, ultimately leading to better patient outcomes and enhanced quality of care. For instance, in December 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the data shows that there were 14,100 doctor-certified deaths from CHD in 2021, rising to 14,900 in 2022. Therefore, an increase in cardiovascular diseases drives the robotic cardiology surgery market.
How is the robotic cardiology surgery market segmented?
The robotic cardiology surgery market covered in this report is segmented –
1) By Product And Service: Robotic Systems, Instruments and Accessories, Maintenance Services, System Services
2) By Equipment Type: Robot Machines, Navigation Systems, Planners And Simulators, Other Equipment Types
3) By End-User: Hospitals, Research Centers
Subsegments:
1) By Robotic Systems: Robotic Surgical Platforms, Minimally Invasive Robotic Systems, Integrated Robotic Systems
2) By Instruments And Accessories: Surgical Instruments, Endoscopic Cameras And Imaging Systems, Accessory Kits For Robotic Systems
3) By Maintenance Services: Preventive Maintenance Services, Repair And Replacement Services, Calibration Services
4) By System Services: Installation and Setup Services, Training And Support Services, Upgrades And Software Maintenance
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/robotic-cardiology-surgery-global-market-report
Who are the top competitors in the robotic cardiology surgery market?
Major companies operating in the robotic cardiology surgery market are Abbott Laboratories, Medtronic PLC, Siemens Healthineers AG, Boston Scientific Corporation, Edwards Lifesciences Corporation, Smith & Nephew PLC, KARL STORZ SE & Co. KG, Renishaw PLC, Think Surgical Inc., Terumo Corporation, CMR Surgical limited, Corindus Vascular Robotics Inc., XACT Robotics Ltd., Titan Medical Inc., Asensus Surgical Inc., Intuitive Surgical Inc., Aurora Surgical Robotics Inc., Precision Robotics Ltd., SS Innovations International Inc., Hansen Medical Inc.
Which key trends are expected to influence the robotic cardiology surgery market in the coming years?
Major companies operating in the robotic cardiology surgery market are focused on developing innovative surgical solutions, such as assistive robotic devices (ARD) to enhance precision in cardiac interventions, minimize invasiveness, and improve patient outcomes through advanced technology integration and real-time analytics. Assistive robotic devices (ARD) refer to robotic systems designed to support individuals with disabilities or limited mobility by aiding in tasks such as movement, communication, or daily living activities. These devices enhance independence and improve the quality of life for users. For instance, in March 2024, CardioPrecision Ltd., a UK-based company that offers robotic surgeries, launched proof-of-concept robotic procedures aimed at implanting an aortic valve replacement through a minimally invasive approach, following successful trials on cadaver models. The robotic system enhances precision and control during the surgery, allowing surgeons to operate with greater accuracy and potentially improving the overall success rate of the procedure. This minimally invasive approach is significant because it can lead to less pain, reduced blood loss, and a lower risk of infection, ultimately facilitating quicker patient recovery.
Which regional trends are influencing the robotic cardiology surgery market, and which area dominates the industry?
North America was the largest region in the robotic cardiology surgery market in 2024. The regions covered in the robotic cardiology surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Robotic Cardiology Surgery Market Report 2025 Offer?
The robotic cardiology surgery market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Robotic cardiology surgery is a minimally invasive surgical technique where surgeons use robotic systems to perform procedures on the heart. These robotic systems provide enhanced precision, flexibility, and control through small incisions, often resulting in less pain, reduced risk of infection, shorter hospital stays, and quicker recovery times for patients compared to traditional open-heart surgery.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20615
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
